期刊文献+

Role of RANTES and Its Receptor in Gastric Cancer Metastasis 被引量:1

Role of RANTES and Its Receptor in Gastric Cancer Metastasis
下载PDF
导出
摘要 This study examined the role of regulated upon activation normal T cell expressed and secreted(RANTES) and its receptor C-C chemokine receptor type 5(CCR5) in gastric cancer metastasis and the associated mechanism.The expression of RANTES and CCR5 was detected by using immunohistochemical staining and Western blotting in the gastric cancer tissues obtained from 60 gastric cancer patients with or without lymph node metastasis(n=30 in each).The results showed that the expression levels of RANTES and CCR5 were higher in gastric cancer with lymph node metastasis than in that without metastasis(P0.05).The expression levels of RANTES in 30 lymph nodes with cancerous invasion were higher than in 30 normal lymph nodes(P0.05).Chemotactic test revealed that the number of migrating gastric cancer cells(n=295.0±54.6) induced by the protein of cancer-invading lymph nodes was greater than that by the protein mixture from cancer-invading lymph nodes and RANTES antibody(n=42.5±11.6)(P0.05).RT-PCR showed that the expression levels of the main Th1 cytokines(IL-2,γ-IFN) were lower in gastric cancer with lymph node metastasis(2.22±0.90,3.26±1.15 respectively) than in that without metastasis(3.07±1.67,4.77±1.52 respectively)(P0.05),but the expression level of the main Th 2 cytokine(IL-10) was higher in gastric cancer with lymph nodes metastasis(6.06±2.04) than in that without metastasis(4.88±1.87)(P0.05).It was concluded that RANTES and its receptor CCR5 may contribute to gastric cancer metastasis through influencing the balance of Th1/Th2.RANTES and CCR5 may become a marker of gastric cancer metastasis. This study examined the role of regulated upon activation normal T cell expressed and secreted(RANTES) and its receptor C-C chemokine receptor type 5(CCR5) in gastric cancer metastasis and the associated mechanism.The expression of RANTES and CCR5 was detected by using immunohistochemical staining and Western blotting in the gastric cancer tissues obtained from 60 gastric cancer patients with or without lymph node metastasis(n=30 in each).The results showed that the expression levels of RANTES and CCR5 were higher in gastric cancer with lymph node metastasis than in that without metastasis(P0.05).The expression levels of RANTES in 30 lymph nodes with cancerous invasion were higher than in 30 normal lymph nodes(P0.05).Chemotactic test revealed that the number of migrating gastric cancer cells(n=295.0±54.6) induced by the protein of cancer-invading lymph nodes was greater than that by the protein mixture from cancer-invading lymph nodes and RANTES antibody(n=42.5±11.6)(P0.05).RT-PCR showed that the expression levels of the main Th1 cytokines(IL-2,γ-IFN) were lower in gastric cancer with lymph node metastasis(2.22±0.90,3.26±1.15 respectively) than in that without metastasis(3.07±1.67,4.77±1.52 respectively)(P0.05),but the expression level of the main Th 2 cytokine(IL-10) was higher in gastric cancer with lymph nodes metastasis(6.06±2.04) than in that without metastasis(4.88±1.87)(P0.05).It was concluded that RANTES and its receptor CCR5 may contribute to gastric cancer metastasis through influencing the balance of Th1/Th2.RANTES and CCR5 may become a marker of gastric cancer metastasis.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2011年第3期342-347,共6页 华中科技大学学报(医学英德文版)
基金 supported by a grant from Natural Sciences Foundation of Hubei Province of China (No. 2006ABA098)
关键词 regulated upon activation normal T cell expressed and secreted gastric cancer METASTASIS CHEMOTAXIS regulated upon activation normal T cell expressed and secreted gastric cancer metastasis chemotaxis
  • 相关文献

参考文献28

  • 1Zhao-Hui Huang,Dong Hua,Xiang Du,Li-Hua Li,Yong Mao,Zhi-Hui Liu,Ming-Xu Song,Xi-Ke Zhou.ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer[J].World Journal of Gastroenterology,2008,14(41):6401-6407. 被引量:7
  • 2Peng Zhang,Hong Li,Mo-Li Wu,Xiao-Yan Chen,Qing-You Kong,Xiao-Wei Wang,Yuan Sun,Shu Wen,Jia Liu.c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells[J]. Journal of Neuro - Oncology . 2006 (2)
  • 3A. Ben-Baruch.The multifaceted roles of chemokines in malignancy[J]. Cancer and Metastasis Reviews . 2006 (3)
  • 4Vaday GG,Peehl DM,Kadam PA,et al.Expression of CCL5 (RANTES) and CCR5 in prestate cancer. Prostate . 2006
  • 5Robinson SC,Scott KA,Wilson JL,et al.A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Research . 2003
  • 6Vitiello PF,Shainheit MG,Allison EM,et al.Impact of tumor-derived CCL2 on T cell effector function. Immunology Letters . 2004
  • 7Borczuk AC,Papanikolaou N,Toonkel RLet al.Lung adenocarcinoma invasion in TGFβRⅡ-deficient cells is mediated by CCL5/RANTES. Oncegene . 2008
  • 8Ben-Baruch A.Organ selectivity in metastasis: regulation by chemokines and their receptors. Clinical and Experimental Metastasis . 2008
  • 9Yaal -Hahoshen N,Shina S,Leider -Trejo L,et al.The chemokine CCL5 as a potential prognostic factor predicting disease progression in stageⅡbreast cancer patients. Clinical Cancer Research . 2006
  • 10Soria G,,Yaal-Hahoshen N,Azenshtein E,et al.Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer:a basis for tumor-promoting interaction. Cytokine . 2008

二级参考文献1

共引文献6

同被引文献19

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部